chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Positive COVID 19; Positive COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 84-year-old male patient received BNT162b2 (BNT162B2), on 28Jan2021 as dose 1, single (Lot number: EL3247), on 19Feb2021 as dose 2, single (Lot number: EL9263), in right arm, on 04Oct2021 as dose 3 (booster), single (Lot number: FF2590), in right arm and on 26Apr2022 as dose 4 (booster), single (Lot number: FJ9943) at the age of 82 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LOVASTATIN, stop date: 06Jun2022. The following information was reported: VACCINATION FAILURE (medically significant) with onset 07Jun2022, outcome "unknown", COVID-19 (medically significant) with onset 07Jun2022, outcome "not recovered" and all described as "Positive COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Jun2022) Positive; (16Jun2022) Negative; (21Jun2022) Positive. Therapeutic measures were taken as a result of covid-19.  Clinical Course: Tested Positive COVID19 07Jun2022, took Paxlovid 5 days 08Jun2022 to 12Jun2022. Tested negative 16Jun2022. On 21Jun2022 not feeling well tested Positive COVID 19 again. Milder symptoms.
Information has been received from a medical assistant concerning unspecified number of patients with unknown age and gender. No current or historical conditions were reported. On unspecified dates the patients were administered with doses of VARIVAX (Merck) that underwent temperature excursion. No adverse experiences were reported. Outcome of the adverse event was unknown. The reporter considered the event to be not related to VARIVAX (Merck). This is one of several reports received from the same source (MARRS # 1503USA000906 and MARRS # 1503USA007019). Additional information has been requested.
Information has been received from a physician concerning an approximately 46 year old female with no past medical history who on 09/25/2001 and 10/20/2001 was vaccinated SC with a first and second dose of varicella vaccine. There was no concomitant medication. Subsequently the pt was tested and found to have a negative titer. Unspecified medical attention was sought. Follow-up info from a physician indicated that there were no adverse events. "Pt given two shots approximately 4 weeks apart. Pt sent for titer but apparently commercially available tests do not detect varicella titer s/p vaccination." No further info is available.
Initial report received from a Consumer (the patient) on 05 November 2014. A 63-year-old male patient had received a dose of FLUZONE QIV, (batch number U1190AA, dose in series, route and site of vaccination not reported) on 31 October 2014. The patient had no illness at the time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions were not reported. On 31 October 2014, same day after vaccination, the patient experienced "not feeling well" and next morning had fever to 101F, chills, myalgia, joint pain and lethargy On 05 November 2014, the patient was still having chills, myalgia, lethargy. Also stated that the patient had swelling, redness, soreness at area around injection site. Corrective treatment and laboratory data was not reported. At the time of this report, the patient had not recovered. Documents held by sender: none.
Pt received immunization on 09/07/04. Area was little red that evening. Next day was worse, by 09/09/04, area was 5x4.5 inches, red, warm to touch, swollen and painful. Pt was given Zyrtec and to follow up if got worse.
Patient reports reaction at the site of injection, redness, swelling, hard and hot to the touch for greater than 7 days. Patient was evaluated by a physician and prescribed a course of Cephalexin. Patient reports condition improving  24 hours after start of antibiotic.
Pt exhibited pale, cool, clammy skin. Heart rate elevated >100bpm. Verbally c/o dizziness, chest discomfort (sternal).
Information has been received from a registered nurse for VARIVAX, a Pregnancy Registry product, concerning a female patient of unknown age. The patient's history of previous pregnancies and live births were not known. The patient might have vaccinated with VARIVAX (lot number, dose, route, injection site and indication were not reported) on an unknown date. No other co-suspects were reported. No concomitant medications were reported. Subsequently, the patient was in fact pregnant. The LMP and EDD were not known. Initial exposure to VARIVAX was unknown. The outcome was unknown at the time of report. The patient had went to the office for medical attention. Follow-up information has been received from a registered nurse concerning a 17 year old female patient who had been vaccinated with a dose of VARIVAX and was pregnant. No LMP or gestation date provided. No adverse effects reported. Additional information has been requested.
About 1 and 1/2 hrs after the injection, the site of the injection I had a hard bump, back and knees were hurting a little, and about 5hrs later all around my mouth I had what looked like eczema blisters which lasted for about 14 days. I applied Docosanol cream, 10% and they have now cleared up completely.
No additional AE's noted; temperature excursion for frozen products; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 21-APR-2021, the patient was vaccinated with dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) dose 1, lot # T013536, expiration date: 17-OCT-2021 (strength, route of administration and exact dose were not reported) for prophylaxis.  On an unknown dates, the dose of the vaccine was exposed to temperature excursion at 14.1 Fahrenheit degrees (F) for 1 hour and at 26 F for 2 hours. There was no previous temperature excursion reported. The call was due to digital data logger. No additional adverse event was reported (linked report: 2104USA007083).
I started feeling COVID-19 symptoms on 11/07/2022. I went to the Dr.'s office because I felt like I had a sinus infection I also had fatigue; cough; low grade fever and lost my sense of smell and taste. Tested positive on 11/08/2022 and did not test negative until 11/26/2022.
Information has been received from a health professional concerning an approx. 8 year old female who was vaccinated with varicella virus vaccine live on an unknown date. She presented to her doctor's office with a severe looking rash on the inside of her thigh (side unknown) that was thought to be herpes zoster. When the child was examined, chickenpox lesions were found on the upper chest. It was noted that samples were taken to be sent to the CDC. It was noted that there was swelling at the site. The physician felt there was an infection and the child was admitted to the hospital. She was found to have "necrosis from a muscle abscess in her thigh". A drain was put into the leg to help drain pus that resulted from the necrotizing fasciitis. It was noted that the muscle abscess was thought to be a "reaction to the herpes zoster rash". Follow-up information has been received from a physician and a health professional who states this child was previously healthy with no known immunosuppression or on any medication within at least 30 days prior to these events. The pt's mother reported that vesicular lesions began on 5/8/01 on the child's thorax, legs and arms. On 5/13/01, the dermatomal lesions began to develop on the child's left leg. When the child was seen at the physician's office on 5/14/01, the lesions had scabbed over, but the child had a fever of 104F and complained of pain on the left groin. The child had a classic dermatomal zoster band approx. 4 X 6 along the L1-L2 dermatome. There was edema at the site. It was reported that the child "may have developed herpes zoster on the thigh after a possible case of mild breakthrough chickenpox rash". The child was treated with acyclovir. It was noted that during the week of 5/14/01, the child had received a kick to the groin. The child had begun to recover from the herpes zoster, but on 5/18/01, she developed a fever and pain. She was admitted to the hospital on 5/20/01. At the time of admission there was no zoster rash noted on the child's thigh. When the child continued to complain of pain, a groin CT scan was done which revealed a large abscess (14 X 13). The abscess required surgical intervention with an incision, drainage and placement of a Penrose drain. A culture from the drainage showed staphylococcus aureus and the pt was treated with IV oxacillin (manufacturer unknown). The child was discharged from the hospital on 5/24/01. It was suggested that the pt have repeat blood work done in 6 weeks. Recovery status was not reported. Additional information is expected. The follow-up states that it was noted that the rash healed in less than 4 weeks and that the child missed 14 days of school. Additional info is expected.
This spontaneous report as received from a health worker refers to a patient of unknown age. On 14-SEP-2013 the patient was vaccinated with VARIVAX (Merck) (strength, dose, frequency and lot # were not provided). On 27-SEP-2013 the patient was vaccinated with MMR II (strength, dose, frequency and lot # were not provided). No adverse symptoms reported. Additional information has been requested.
Patient reported she had never had a COVID19 vaccine. A search in system showed that the patient had had 2 doses of the Moderna vaccine.
2-24-21 Notes: Patient c/o of joint pain and tingling in left hand and lt arm. BP was taken in the 1st 5 minns of c/o, after 15 mins of sitting and observation patient become to feel normal.. Patient observed sitting in observation area. About 15 mins into observvation patient stated she is expericing some joint pain & tingling in Lt hand and slowly moving towards L elbow. Patient states she has chronic Hypertension and currently taking olmesartan 20 mg and metoprolol Suc ER 25 mg dosage of BP meds around 630 am this morning. Patient recieved 1st dose of Moderna vaccination around 11am this morning. Vitals was taken on patient around 1130am. 1st BP 192/124 P 102 R20 O2 98 Patient states if she misses a dose of BP medication her Bp shoots up to 195/178. 2nd Bp taken about 10 mins after 1st BP vitals 187/125- P106 R18 O2 99. Patient stated she started feeling a little better after 2nd BP was taken and tingling in hands went away. Patient instructed to drink some water and remain an extra 5-10 mins. Also patient was instructed to inform doctor of matter as soon as possible for further instructions. Patient was once again educated on s/s of vaccinations and s/s of an allergic reaction. Patient recieved her 1st dose of Moderna in Lt arm and give by innoculator. 3rd set of vitals 175/103 P 102 O2% 98 taken around 1200pm. Patient stated that she is feeling fine and was ok to drive home.
experienced adverse reactions after receiving flu vaccines; Initial information received on 13-Apr-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves male patient of an unknown age who experienced adverse reactions after receiving INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious adverse reaction after receiving flu vaccines (adverse event) following the administration of INFLUENZA VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was adverse reactions after receiving flu vaccines.  It was not reported if the patient received a corrective treatment.  The outcome of the event was not reported.  Documents held by sender: none.
pain in the knee was still there; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (pain in the knee was still there) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 009C21A) for COVID-19 vaccination.     The patient's past medical history included Knee surgery NOS. Concomitant products included TRAMADOL for an unknown indication.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced ARTHRALGIA (pain in the knee was still there). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, ARTHRALGIA (pain in the knee was still there) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Med Info Agent:  AE: Patient states that she received the first dose of the Moderna vaccine on 16APR2021 (Lot #: 037B21A, Exp Unknown) in her left arm. The next day on 17APR2021 she felt severe joint pain in her left knee where she had surgery several years ago. She then had her second vaccine on 21MAY2021 (Lot#: 009C21A, Exp Unknown) in the left arm but the pain in the knee was still there. She states her knee is popped so she has an immobilizer to keep it in place.  She has been to the ER and has also seen an orthopedic doctor. She has now been scheduled for an MRI.   Consent for follow up with safety given
Patient started to experience swelling of the tongue approximately 5 mins after the vaccine was given. 50 mg of diphenhydramine was given. a few mins later, patient started experiencing shortness of breath.  0.15 mg of epi were given. The dose was repeated again approximately 20 mins later.  15 mins later, NC was put on the patient for about 10 mins.  Later on that night, patient went to an emergency department where steroids, albuterol nebs, and another 50 mg of Benadryl were administered.
Ringing in my ears on both sides.  A continual buzzing that does not stop.
FEVER; HEADACHE; BODY ACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 06:00 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 09-MAR-2021, the subject experienced body ache. On 10-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 102 F, 101.6 F, 100 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, body ache, and headache. This report was non-serious.
48 hours after second vaccine I woke up with pain under my left arm (arm I got the vaccine in) lymph node.  Sore and tenderness lasted 24 to 36 hours.
Developed a severe headache around 1 PM of the day she received her vaccine, some general tingling non-specific; sever headache lasted until 9 PM that evening, relieved with medication but in the morning continued to have headache although more mild then previously.  Was better by the 3rd day.
Started noticing shortness of breath upon exertion; I was also having some Malaise. Some dry/brittle fingernails some of the classic symptoms of anemia. March 30 when you gave blood my finger stick hemoglobin was 12.5 and usually it is 13.4 or 13.5 (in December 2020). I went to see Dr on April 19th and they drew labs. Iron supplement Fergon to take for one month. May 24th re-drew my blood and hemoglobin was back up to 13.4. Stopped Fergon on June 4th per doctor's recommendation. My symptoms have gone away since I've taking that iron. I will get blood drawn again August 2021.
heard people talking to me a few times (thought my husband said something when he didn't); confused disoriented and heard people talking to me a few times; dizzy / lightheaded; disoriented; This is a spontaneous report from a contactable consumer (patient). A 36-year-old non-pregnant female patient received bnt162b2 (BNT162B2), second single dose via an unspecified route of administration, administered in arm left on 24Mar2021 16:00 (Batch/Lot number was not reported) for covid-19 immunisation at age of 36-year-old. The patient previously received first single dose of bnt162b2 on 27Mar2021 at 16:00 on left arm for COVID-19 immunisation at age of 36-year-old. Medical history included asthma, high blood pressure, heartburn and acid reflux. The patient had Known allergies for Amoxicillin and penicillin bacterium. Other medications in two weeks included blood pressure and acid reflux medications. No other vaccine in four weeks received. No Covid prior vaccination and no Covid tested post vaccination. On 27Mar2021 at 12:00, following 2nd dose lightheaded dizzy confused disoriented and heard people talking to me a few times (thought my husband said something when he didn't) 18 weeks later still feel dizzy and lightheaded all day every day, and disoriented/confused at times. No treatment received for the events. Outcome of the events was not recovered.   Information about the Lot/batch number has been requested.
It felt like a combination of chicken pox and shingles and itched for a couple days and broke out into a bad rash on legs, back, and arm.
About ten minutes after the vaccine Headache been almost immediately that was blinding and body aches as well. These symptoms occurred for approximately 3 months. After reaching out to my primary care, I was given a blood panel and they found inflammation throughout my entire body and was put on Prednisone for 2 weeks. This prescription helped out extremely well however after the two weeks I was having to use Tylenol, which did not help.  Booster shot October 2021, I had the same exact symptoms and they have only gone away after the beginning of February. Marking it a 3 month timeframe of symptoms as well.
Patient reported swelling in arm and lymph node. Patient also had extensive bruising on the INSIDE of arm and on side of chest. Bright blue and purple bruising not at the injection sight but on the side of the body of the injection. She also reported red spots on side of abdomen and some slight discomfort breathing
7 1/2 x 8 1/2 cm soft tissue mass at injection site LT upper arm.
pt who had her 14mo hmv and imms 10 days ago. imms inclunded vzv and mmr.  +ve fever of 101.7 in last 24hrs, self resolved since but now has a rash on body.  pt is acting well otherwise.  probable delayed reaction to VZV vaccine w/ minor wild type seroconversion  expect mild sxs to promptly abate in patient in next 48hrs  debate about its infective nature. had talked to Facility about a similar case. not reportable.   however, to assume it is contagious, to quarantine until last lesion crusts over.   pt was not around anyone who was pregnant (mother is not pregnant) or immunocompromised from my understanding as rev'd w/ parents.  topical otc abx use on any itchy lesion. otherwise avoid unnecessary rx  prn antipyretic use only.
pregnant; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 29-Apr-2021. On 26-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). On 26-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: No specific follow-up information recorded.
Dizziness, weak and nausea. Diaphoretic and pale. Arm numbness and tingling.
48 hours of extreme flulike conditions. Consisting mostly of severe headaches, body aches, and skin sensitivity. Glandular pain & soreness. Lower back pain, possibly kidney pain.
angioedema of the upper lips started solu-medrol, benadryl and pepcid
Information regarding PREVNAR 13 was received from a physician regarding a patient who experienced "large swelling areas in the limbs which was more than expected". The patient received a dose on an unspecified date. MEDICAL HISTORY: Relevant medical history was not provided. PRODUCT DETAILS: Indication of PREVNAR 13 was immunisation. Product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day (intramuscular). CONCOMITANT THERAPY: Concomitant medications were not reported. EVENT DETAILS: The patient experienced "large swelling areas in the limbs which was more than expected". Outcome was unknown. No additional information was available at the time of this report. RELATED CASE (S): See related case (s): US WYE H18212110 (adverse event, expedited).
ileocolic intususception starting on 6/20.  was in ER by 20:00 6/20 where she was admitted.
Received rabies immunoglobin with in 2 hours, front of forearm had red circle with white inside of that it was warm to touch.  Also the two places on thighs were shots given were red and warm.  All 3 places were itching.  1 shot Benadryl given.
Presented with rapid onset febrile symptoms (chills, aches, profound lethargy, severe headache with photophobia). One episode of vomiting but o/w without GI symptoms. Lungs clear, denies sore throat or cough. Temp remained around 102.0 for approximately 15 hours despite ASA and APAP, then abruptly returned to normal with complete resolution of symptoms.
within approximately 10-20 seconds after getting the vaccine I felt generally unwell, specific symptoms are difficult to distinguish, I notified staff that I was not feeling right, they ultimately recommended I lie on the ground, within 3-5 seconds of lying down I lost consciousness, unclear how long I was out but estimated around 10-20 seconds at most. I was then evaluated by EMS with ekg and positional BP/HR, all which were normal. I refused to be transported to a hospital.
No additional AEs; received by the intramuscular route instead of recommended subcutaneous route; This spontaneous report was received from a medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not provided.  On 02-MAR-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) rHA, 0.5 milliliter, lot # S037503, expiration date was reported and validated as 20-NOV-2021, and varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, lot # T002843, expiration date reported and validated as 23-JAN-2022, by the intramuscular (IM) route instead of recommended subcutaneous (SQ) route, for prophylaxis (subcutaneous injection formulation administered by other route). Anatomical location was not reported for both vaccines. No additional adverse events (AEs) (no adverse event).